Literature DB >> 9951518

[Survival time of exclusively irradiated NSCLC patients: the viewpoint of a clinical biologist. Concerning the article by R. Wilhelm et al in Strahlenther Onkol 1988: 174:128-32 (No. 3)].

J Watine, R Fintelmann, J C Charet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9951518     DOI： 10.1007/BF02743461

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  18 in total

1.  Systematic reviewing in laboratory medicine. Position Paper from the IFCC Committee on Systematic Reviewing in Laboratory Medicine.

Authors:  S Sandberg; W Oosterhuis; D Freedman; T Kawai
Journal:  J Int Fed Clin Chem       Date:  1997-12

2.  Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working Party.

Authors:  J P Sculier; M Paesmans; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; J Schmerber; V Giner
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

3.  Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

Authors:  K S Albain; J J Crowley; M LeBlanc; R B Livingston
Journal:  J Clin Oncol       Date:  1991-09       Impact factor: 44.544

4.  Analysis of three-year survivors among patients with advanced inoperable non-small cell lung cancer.

Authors:  A Kojima; T Shinkai; K Eguchi; Y Sasaki; T Tamura; Y Ohe; F Oshita; T Miya; H Okamoto; H Kondo
Journal:  Jpn J Clin Oncol       Date:  1991-08       Impact factor: 3.019

Review 5.  Prognostic factors in lung cancer: tables and comments.

Authors:  G Buccheri; D Ferrigno
Journal:  Eur Respir J       Date:  1994-07       Impact factor: 16.671

Review 6.  The future of prognostic factors in outcome prediction for patients with cancer.

Authors:  L P Fielding; C M Fenoglio-Preiser; L S Freedman
Journal:  Cancer       Date:  1992-11-01       Impact factor: 6.860

7.  Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

Authors:  M Paesmans; J P Sculier; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; R Sergysels; P Mommen
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

8.  Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group.

Authors:  M H Gail; R T Eagan; R Feld; R Ginsberg; B Goodell; L Hill; E C Holmes; J M Lukeman; C F Mountain; R K Oldham
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

9.  A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy.

Authors:  T Shinkai; K Eguchi; Y Sasaki; T Tamura; Y Ohe; A Kojima; F Oshita; T Miya; H Okamoto; K Iemura
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Prognostic factors in inoperable adenocarcinoma of the lung: a multivariate regression analysis of 259 patients.

Authors:  J B Sørensen; J H Badsberg; J Olsen
Journal:  Cancer Res       Date:  1989-10-15       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.